Has Karen Tobin received payments from drug or device companies?

Yes. Drug and device makers reported $2,725 in general payments to Karen Tobin across 192 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Karen Tobin did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Karen Tobin come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Karen Tobin

Neurology · Washington, PANPI 1396707683

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,191 and has fallen 99.2% since, to $17 in 2024.

$2,725in general payments, 2019–2025

Across 192 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$508
UCB, Inc.$215
Supernus Pharmaceuticals, Inc.$198
Teva Pharmaceuticals USA, Inc.$185
AbbVie$148
Sunovion Pharmaceuticals Inc.$146
plus $1K from 28 others

What the payments were for

Speaking & faculty fees$903%
Food & beverage$2,63597%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	38	$508
UCB, Inc.	16	$215
Supernus Pharmaceuticals, Inc.	35	$198
Teva Pharmaceuticals USA, Inc.	9	$185
AbbVie	10	$148
Sunovion Pharmaceuticals Inc.	10	$146
Amgen	6	$109
Sanofi	5	$101
Acorda Therapeutics, Inc	5	$90
Biogen	5	$85
Genentech USA, Inc.	6	$79
Tersera Therapeutics LLC	4	$76
EMD Serono, Inc.	4	$75
Acadia Pharmaceuticals Inc	4	$64
Vertical Pharmaceuticals, LLC	3	$60
CSL Behring	3	$58
Assertio Therapeutics, Inc.	3	$58
Adamas Pharmaceuticals, Inc.	3	$56
Amneal Pharmaceuticals LLC	3	$52
Catalyst Pharmaceuticals, Inc.	1	$37
Lilly USA, LLC	2	$36
SK Life Science, Inc.	2	$35
Lundbeck LLC	2	$30
Medline Industries LP	1	$30
Abbott	2	$26
GE HealthCare	2	$26
Portola Pharmaceuticals, LLC	1	$25
Neurocrine Biosciences, Inc.	1	$21
Tanabe Pharma America, Inc.	1	$19
Jazz Pharmaceuticals Inc.	1	$18
Boston Scientific	1	$17
Currax Pharmaceuticals LLC	1	$15
MDD US Operations, LLC	1	$15
Avanir Pharmaceuticals, Inc.	1	$13

How this compares

$2,725 in reported general payments places this provider in the 65th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Other neurology in Washington

Bruce CotugnoWashington$275K
Daniel KremensPhiladelphia$1.8M
Thomas LeistPhiladelphia$1.4M
Jill Giordano FarmerPhiladelphia$1.2M
Ravi DukkipatiYork$936K
Brad KleinAbington$927K
Stephanie Nahas-GeigerPhiladelphia$786K
John KhouryAbington$686K
Amit Bar-OrPhiladelphia$596K
Behrang SaminejadAllentown$594K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →